Pivotal trial of AVXS 101 in patients with spinal muscular atrophy type 1
Phase of Trial: Phase III
Latest Information Update: 16 Jan 2018
At a glance
- Drugs AVXS 101 (Primary)
- Indications Spinal muscular atrophy
- Focus Registrational; Therapeutic Use
- Acronyms STR1VE EU
- 16 Jan 2018 Planned initiation date changed from 1 Jan 2017 to 1 Jan 2018, according to Avexis media release.
- 16 Jan 2018 According to Avexis media release, this trial may expects to start in the first half of 2018. European Medicines Agency helped to design a protocol of this trial.
- 08 Feb 2017 New trial record